• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Medicaid populations can benefit from DM interventions

Article

As the spiraling cost of healthcare continues to strain federal and state budgets, state Medicaid agencies are looking for powerful, workable solutions to the crisis.

As the spiraling cost of healthcare continues to strain federal and state budgets, state Medicaid agencies are looking for powerful, workable solutions to the crisis. Alternatives are needed that do not reduce benefits or tighten eligibility requirements for a population that largely relies on Medicaid as its only source of healthcare coverage.

A successful disease management (DM) program can help stem the rising tide of medical costs. The primary mission of DM is to help individuals with chronic illness reach optimal health while reducing medical costs. By supporting the patient-physician relationship and educating individuals on how to take more responsibility for their health, DM can help prevent costly hospitalizations and emergency department visits.

SUNSHINE STATE'S DM EFFORTS LifeMasters and Florida's Agency for Health Care Administration (AHCA) have worked together since September 2000 in one of the industry's first public-private collaborations, providing Medicaid beneficiaries in northern Florida with DM services for congestive heart failure and all related conditions and comorbidities, including diabetes, COPD, hypertension and depression.

Despite this higher cost, Medicaid DM programs will still generate a positive return on investment (ROI) because of the higher level of program acceptance and adherence by beneficiaries and their physicians, and the lack of other coordination-of-care efforts directed toward the population.

The LifeMasters/AHCA DM program works and proves that DM can take on the multilayered challenges of access, quality, cost, and care coordination with low-income population-and reap millions of dollars of savings in the process. As a result, LifeMasters and AHCA were honored with the 2004 AstraZeneca-National Managed Health Care Congress Partnership Award, which recognizes organizations that demonstrate quality, access, and efficiency of healthcare delivery through the cooperation and collaboration of organizations.

This section is underwritten by an unrestricted editorial grant from NMHCC.

Related Videos
Video 9 - "Denial of Coverage in Fertility Care"
Video 8 - "Risks of Miscarriage and Multiple Births Associated with Fertility Care"
Video 7 - "Fertility Preservation: Egg Freezing Versus Embryo Freezing"
Video 6 - "Family Building Costs, Barriers, and Dropout Rates Associated with Fertility Care"
Video 5 - "Closing Payer Gaps and Improving Fertility Care Access"
Video 4 - "Increasing Employer Coverage and Maximizing Fertility Benefits "
Video 5 - "Relevance of NUTURE Study Findings for Patients, Payers, Providers"
Video 3 - "Improving IVF Success Rates & Utilizing AI in Fertility Health Care"
Video 2 - "Holistic Fertility Management and Payer Collaboration"
Video 5 - "Relevance of NUTURE Study Findings for Patients, Payers, Providers"
Related Content
© 2024 MJH Life Sciences

All rights reserved.